Monday, March 6th 2023 (13:00 - 17:30)
Provincieplein 1, 3010 Leuven, België
€150.00 for non-members
€100.00 for members
flanders.bio, BioWin, BeCRO
In line with their previous events on clinical trials, flanders.bio, BioWin and BeCRO are very pleased to invite you to their next conference in Leuven.
Belgium has a long history of excellent clinical research addressing a wide range of therapeutic domains thanks to a unique health ecosystem, the quality of the clinical centres and the real-life expertise of investigators. Clinical research refers to a multistakeholder landscape in which tracing its path can be a challenging task, in particular for SMEs willing to bring their new health innovations ultimately to the patients.
The increasing importance of data intelligence, the necessary emphasis on patient input, the trend towards more personalised therapeutic approaches all asks for new clinical trial setups and models, from the preparatory phase up to the follow-up.
During the event you will hear the voice of industry (biopharma, biotech and medtech), learn about the hospital’s perspective, and the position of the patient therein. In addition, you will be updated on a number of new trends in the clinical trial landscape.
Mark the afternoon (starting at 13:00) of 6 March in your agenda to attend this interactive day with key players and stakeholders in the Belgian biopharma ecosystem.
13h30 - 13h40
13h40 - 14h00
The development of a Belgian Clinical Trial Portal: a multi-stakeholder approach
Mitchell Silva (co-fouder, Esperity-PatientCentrics)
14h00 - 14h20
Key Success Factors to Accelerate the Translation of Research Solutions to the Patient. What could we do in Belgium to make it possible
Luc Uylenbroeck (Head of Corporate Portfolio Management and Early Solutions Strategy & Operations, UCB)
14h20 - 14h40
An innovative cancer treatment modality at patient’s home: a recent experience from a biotech company
Frédéric De Coninck (CEO, InhaTarget Therapeutics)
14h40 - 15h00
Spinovit, a case study of closing the gap between bench and bedside
Nancy Van Overstraeten (CEO, Spinovit)
15h00 - 15h30
15h30 - 15h50
Bringing Clinical Trials to Patients home
Ine Vercammen (Study Operations Manager, Delta Healthcare Consulting)
15h50 - 16h10
Natural Language Processing-enabled decision support for complex clinical trials – from a hospital perspective
Eveline Dullaers (Healthcare Solution Lead, IQVIA )
16h10 - 16h30
Patient recruitment approaches with disruptive methods : a Case study where Blockchain would change the Game!
Olivier Simon (Visoclinical)
16h30 - 16h50
Early access program as a pathway to bring innovation to market
Patrick Larcier (Senior Director,
16h50 - 17h00
17h00 - 17h25
Perspectives form a university hospital CEO: is the glass half-empty, or half-full?
Marc Noppen (CEO, UZ Brussel)
17h25 - 17h30
17h30 - 19h00
Healthcare Solution Lead, IQVIA
Study Operations Manager, Delta Healthcare Consulting
CEO, UZ Brussel
Nancy Van Overstraeten
Senior Director, Strategic Product Development Solutions, PharmaLex